Deborah M. Autor - Dec 23, 2021 Form 3 Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role
Director
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Stock symbol
PRDS
Transactions as of
Dec 23, 2021
Transactions value $
$0
Form type
3
Date filed
12/27/2021, 04:09 PM
Next filing
Jun 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PRDS Stock Option (Right to Buy) Dec 23, 2021 Common Stock 70.4K $4.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on the 29th day of each month following July 29, 2021, subject to a continued service relationship.

Remarks:

Exhibit 24 - Power of Attorney Effective immediately following the effective time of the merger pursuant to that certain Agreement and Plan of Merger dated as of June 29, 2021, as amended, by and among Pardes Biosciences Sub, Inc. (f/k/a Pardes Biosciences, Inc.), Issuer (f/k/a FS Development Corp. II), and certain other parties thereto, the reporting person became a director of the Issuer.